Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by (1,066)

Items 301–400 of 1,066

1. Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
   Syreeta DeCordova, Abhishek Shastri, Anthony George Tsolaki, Hadida Yasmin, Lukas Klein, Shiv K. Singh, Uday Kishore · 2020 · Frontiers in Immunology
2. Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
   Shannon E. Fogh, David William Andrews, Jon Glass, Walter John Curran, Charles Glass, Colin Eamon Champ, James J. Evans, Terry Hyslop, Edward C. Pequignot, Beverly Downes et al. · 2010 · Journal of Clinical Oncology
3. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
   Pierre Bady, Davide Sciuscio, Annie‐Claire Diserens, Jocelyne Bloch, Martin J. van den Bent, Christine Marosi, Pierre-Yves Dietrich, Michael Weller, Luigi Mariani, Frank L. Heppner et al. · 2012 · Acta Neuropathologica
4. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
   Tracy T. Batchelor, Elizabeth Robins Gerstner, Kyrre E. Emblem, Dan Gabriel Duda, Jayashree Kalpathy–Cramer, Matija Snuderl, Marek Ancukiewicz, Pavlina Polaskova, Marco C. Pinho, Dominique L. Jennings et al. · 2013 · Proceedings of the National Academy of Sciences
5. Convection-Enhanced Delivery
   Amol M. Mehta, Adam M. Sonabend, Jeffrey N. Bruce · 2017 · Neurotherapeutics
6. Targeting cellular pathways in glioblastoma multiforme
   Joshua R. D. Pearson, Tarik Regad · 2017 · Signal Transduction and Targeted Therapy
7. MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges
   Alireza Mansouri, Laureen D. Hachem, Sheila Mansouri, Farshad Nassiri, Normand Laperrière, Daniel Xia, Neal Ian Lindeman, Patrick Yung Wen, Arnab Chakravarti, Minesh P. Mehta et al. · 2018 · Neuro-Oncology
8. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
   Marc Charles Chamberlain, Michael Glantz, Lisa M. Chalmers, Alixis Van Horn, Andrew Edward Sloan · 2006 · Journal of Neuro-Oncology
9. The molecular profile of microglia under the influence of glioma
   W. Li, Manuel B. Graeber · 2012 · Neuro-Oncology
10. International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme
    Wilson Roa, Lucyna Kępka, Narendra Kumar, Valery Sinaika, Juliana Matiello, Darejan Lomidze, Dalenda Hentati, Douglas Guedes de Castro, Katarzyna Dyttus‐Cebulok, Suzanne Drodge et al. · 2015 · Journal of Clinical Oncology
11. 5-ALA and FDA Approval for Glioma Surgery
    Hadjipanayis, Constantinos G., Stummer, Walter · 2019 · Journal of Neuro-Oncology
12. Advances in local therapy for glioblastoma — taking the fight to the tumour
    Thomas S. van Solinge, Lisa Nieland, Ennio Antonio Chiocca, Marike L. D. Broekman · 2022 · Nature Reviews Neurology
13. Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells
    Murielle Mimeault, Surinder K. Batra · 2013 · Journal of Cellular and Molecular Medicine
14. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
    Dominik Sturm, Stefan Michael Pfister, David Jones · 2017 · Journal of Clinical Oncology
15. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
    Martin J. van den Bent, C. Mircea S. Tesileanu, Wolfgang Wick, Marc Sanson, Alba Ariela Brandes, Paul M. Clément, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Jean Français Baurain et al. · 2021 · The Lancet Oncology
16. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
    Fred C. Lam, Stephen W. Morton, Jeffrey B. Wyckoff, Tu‐Lan Vu‐Han, Mun Kyung Hwang, Amanda Maffa, Elena Balkanska-Sinclair, Michael B. Yaffe, Scott Floyd, Paula Therese Hammond · 2018 · Nature Communications
17. Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group
    Kenneth J. Cohen, Richard L. Heideman, T. Zhou, Emiko J. Holmes, Robert S. Lavey, Éric Bouffet, Ian F. Pollack · 2011 · Neuro-Oncology
18. Hematogenous dissemination of glioblastoma multiforme
    Carolin Müller, Johannes Holtschmidt, Martina Auer, Ellen Heitzer, Katrin Lamszus, Alexander Schulte, Jakob Matschke, Sabine Langer-Freitag, Christin Gasch, Malgorzata Stoupiec et al. · 2014 · Science Translational Medicine
19. Phase II Study of Imatinib Mesylate Plus Hydroxyurea in Adults With Recurrent Glioblastoma Multiforme
    David A. Reardon, Merrill J. Egorin, Jennifer A. Quinn, Jeremy N. Rich, Idharan Gururangan, James J. Vredenburgh, Annick Desjardins, Sith Sathornsumetee, James M. Provenzale, James E. Herndon et al. · 2005 · Journal of Clinical Oncology
20. Glioblastoma multiforme: State of the art and future therapeutics
    DavidH. Harter, TaylorA Wilson, Matthias A. Karajannis · 2014 · Surgical Neurology International
21. Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single Institution
    Stephanie Elisabeth Combs, Christoph Thilmann, Lutz Edler, Jürgen Debus, Daniela Schulz–Ertner · 2005 · Journal of Clinical Oncology
22. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo
    Michael Zhang, Gregor Hütter, Suzana Assad Kahn, Tej Deepak Azad, Sharareh Gholamin, Chelsea Y. Xu, Jie Liu, Achal Singh Achrol, Chase Richard, Pia Sommerkamp et al. · 2016 · PLoS ONE
23. Resection and survival in glioblastoma multiforme: An RTOG recursive partitioning analysis of ALA study patients
    Uwe Pichlmeier, Andrea Bink, Gabriele Schackert, Walter Stummer · 2008 · Neuro-Oncology
24. Health-related quality of life in patients with glioblastoma: a randomised controlled trial
    MARTIN J.B. TAPHOORN, Roger Stupp, Corneel Coens, David Osoba, Rolf Dieter Kortmann, Martin J. van den Bent, Warren P. Mason, R.O. Mirimanoff, Brigitta G. Baumert, Elizabeth A. Eisenhauer et al. · 2005 · The Lancet Oncology
25. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
    Joseph Flores‐Toro, Defang Luo, Adithya Gopinath, Matthew R. Sarkisian, James J. Campbell, Israel F. Charo, Rajinder Singh, Thomas J. Schall, Meenal Datta, Rakesh K. Jain et al. · 2019 · Proceedings of the National Academy of Sciences
26. Gboxin is an oxidative phosphorylation inhibitor that targets glioblastoma
    Shi, Yufeng, Lim, S. Kyun, Liang, Qiren, Iyer, Swathi V., Wang, Hua-Yu, Wang, Zilai, Xie, Xuanhua, Sun, Daochun, Chen, Yu-Jung, Tabar, Viviane et al. · 2019 · Nature
27. Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study Group
    Kunwar, Sandeep, Prados, Michael D., Chang, Susan M., Berger, Mitchel S., Lang, Frederick F., Piepmeier, Joseph M., Sampson, John H., Ram, Zvi, Gutin, Philip H., Gibbons, Robert D. et al. · 2007 · Journal of Clinical Oncology
28. Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma
    Shabierjiang Jiapaer, Takuya Furuta, Shingo Tanaka, Tomohiro Kitabayashi, Mitsutoshi Nakada · 2018 · Neurologia medico-chirurgica
29. Brain cancer diagnosis and therapy with nanoplatforms☆
    Y KOO, G REDDY, Mahaveer Swaroop Bhojani, Randy Schneider, M PHILBERT, Al Rehemtulla, Brian Dale Ross, Raoul Kopelman · 2006 · Advanced Drug Delivery Reviews
30. Integrated genomic characterization of IDH1-mutant glioma malignant progression
    Hanwen Bai, Akdes Serin Harmancı, Zeynep Erson-Omay, Jie Li, Süleyman Coşkun, Matthias Simon, Boris Krischek, Koray Özduman, Sacit Bulent Omay, Eric A. Sorensen et al. · 2015 · Nature Genetics
31. Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
    J R Dunn, Atik Baborie, F. Alam, K A Joyce, M Moxham, Ross Sibson, Daniel A. Crooks, David John Husband, Aditya Shenoy, Andrew R. Brodbelt et al. · 2009 · British Journal of Cancer
32. Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas
    Sophie Heuer, Matthias Osswald, Gergely Morten Solecki, Julia Katharina Grosch, Erik Jung, Dieter Lemke, Miriam Ratliff, Daniel Hänggi, Wolfgang Wick, Frank Winkler · 2017 · Neuro-Oncology
33. The Role of Hypoxia in Glioblastoma Invasion
    Ana Rita Monteiro, Richard Hill, Geoffrey John Pilkington, Patrícia A. Madureira · 2017 · Cells
34. Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
    Olivia G. Taylor, Joshua S. Brzozowski, Kathryn Anne Skelding · 2019 · Frontiers in Oncology
35. Molecularly targeted therapy for malignant glioma
    Sith Sathornsumetee, David A. Reardon, Annick Desjardins, Jennifer A. Quinn, James J. Vredenburgh, Jeremy N. Rich · 2007 · Cancer
36. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas
    Tamar R. Berger, Patrick Yung Wen, Melanie Lang‐Orsini, Ugonma Nnenna Chukwueke · 2022 · JAMA Oncology
37. Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features
    Gevaert, Olivier, Mitchell, Lex A., Achrol, Achal S., Xu, Jiajing, Echegaray, Sebastian, Steinberg, Gary K., Cheshier, Samuel H., Napel, Sandy, Zaharchuk, Greg, Plevritis, Sylvia K. · 2014 · Radiology
38. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide
    Giuseppe Caracciolo Minniti, Dante Amelio, Maurizio Amichetti, Maurizio Salvati, Roberta Muni, Alessandro Bozzao, Gaetano Lanzetta, Stefania Scarpino, Antonietta Arcella, Riccardo Maurizi Enrici · 2010 · Radiotherapy and Oncology
39. The Human Glioblastoma Cell Culture Resource: Validated Cell Models Representing All Molecular Subtypes
    Yuan Xie, Tobias Bergström, Yiwen Jiang, Patrik Johansson, Voichita Dana Marinescu, Nanna Lindberg, Anna Segerman, Grzegorz Wicher, Mia Niklasson, Sathishkumar Baskaran et al. · 2015 · EBioMedicine
40. The 2016 World Health Organization classification of tumours of the central nervous system
    Chiara Villa, Catherine Miquel, Dominic Mosses, Michèle Bernier, Anna Luisa Di Stefano · 2018 · La Presse Médicale
41. A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
    James M. Markert, Shantanu N. Razdan, Hui‐Chien Kuo, Alan B Cantor, Anette E. Knoll, Matthias Karrasch, Burt Nabors, Michael Anne Markiewicz, Bonita S. Agee, Jennifer M. Coleman et al. · 2014 · Molecular Therapy
42. Childhood brain tumors: current management, biological insights, and future directions
    Ian F. Pollack, Sameer Agnihotri, Alberto Broniscer · 2019 · Journal of Neurosurgery Pediatrics
43. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications
    Jian Cheng, Jinli Meng, Lei Zhu, Yong Peng · 2020 · Molecular Cancer
44. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance
    Leila Akkari, Robert L. Bowman, Jeremy Tessier, Florian Klemm, Shanna M. Handgraaf, Marnix H. P. de Groot, Daniela F. Quail, Lucie Tillard, Jules Gadiot, Jason T. Huse et al. · 2020 · Science Translational Medicine
45. Metronomics: towards personalized chemotherapy?
    Nicolás André, Manon Carré, Eddy Pasquier · 2014 · Nature Reviews Clinical Oncology
46. T-cell Dysfunction in Glioblastoma: Applying a New Framework
    Karolina I. Woroniecka, Kristen Elizabeth Rhodin, Pakawat Chongsathidkiet, Kristin A. Keith, Peter Edward Fecci · 2018 · Clinical Cancer Research
47. Current FDA-Approved Therapies for High-Grade Malignant Gliomas
    Jacob P. Fisher, David Cory Adamson · 2021 · Biomedicines
48. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival
    Daniel A. Orringer, Darryl Lau, Sameer S. Khatri, Grettel J. Zamora-Berridi, Kathy Zhang, Chris Y. Wu, Neeraj Chaudhary, Oren Sagher · 2012 · Journal of neurosurgery
49. Current trends in the surgical management and treatment of adult glioblastoma.
    Richard M Young, Aria M. Jamshidi, Gregory Davis, Jonathan H. Sherman · 2015 · Europe PMC (PubMed Central)
50. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes
    Gyeungyun Kim, Minkyung Kim, Youngki Lee, Jung Woo Byun, Do Won Hwang, Minhyung Lee · 2019 · Journal of Controlled Release
51. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
    Horbinski, Craig, Berger, Tamar, Packer, Roger J., Wen, Patrick Y. · 2022 · Nature Reviews Neurology
52. Spatiotemporal Evolution of the Primary Glioblastoma Genome
    Jinkuk Kim, In‐Hee Lee, Hee Jin Cho, Chul‐Kee Park, Yang-Soon Jung, Yanghee Kim, So Hee Nam, Byung Sup Kim, Mark D. Johnson, Doo‐Sik Kong et al. · 2015 · Cancer Cell
53. Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery
    Nicholas F. Marko, Robert John Weil, Jason L. Schroeder, Frederick F. Lang, Dima Suki, Raymond A. Sawaya · 2014 · Journal of Clinical Oncology
54. CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
    Stephen Joseph Bagley, Arati Suvas Desai, Gerald P. Linette, Carl H. June, Donald M. O’Rourke · 2018 · Neuro-Oncology
55. Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
    Benito Campos, Feng Wan, Mohammad Reza Farhadi, Aurélie Ernst, Felix Alexander Zeppernick, Katrin Elisabeth Tagscherer, Rezvan Ahmadi, Jennifer Lohr, Christine Dictus, Georg Gdynia et al. · 2010 · Clinical Cancer Research
56. O6‐methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
    Mirjam Hermisson, Andrea Klumpp, Wolfgang Wick, Jörg Wischhusen, Georg Nagel, Wynand Paul Roos, Bernd Kaina, Michael Weller · 2006 · Journal of Neurochemistry
57. Glioma Stem Cell Proliferation and Tumor Growth Are Promoted by Nitric Oxide Synthase-2
    Christine Elissa Eyler, Qiulian Wu, Kenneth Kar-Lung Yan, Jennifer MacSwords, Devin Chandler-Militello, Katherine L. Misuraca, Justin Durla Lathia, Michael T. Forrester, Jeongwu Lee, Jonathan S. Stamler et al. · 2011 · Cell
58. Challenges in glioblastoma research: focus on the tumor microenvironment
    Andréas Bikfalvi, Cristine Alvès da Costa, Tony Avril, Jean‐Vianney Barnier, Luc Bauchet, Lucie Brisson, Pierre‐François Cartron, Hélène Castel, Éric Chevet, Hervé Chneiweiss et al. · 2022 · Trends in cancer
59. Recent Advances in the Treatment of Malignant Astrocytoma
    David A. Reardon, Jeremy N. Rich, Henry S. Friedman, Darell D. Bigner · 2006 · Journal of Clinical Oncology
60. Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
    Dagmar Beier, Jörg Bernhard Schulz, Christoph Patrick Beier · 2011 · Molecular Cancer
61. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
    Shota Tanaka, David N. Louis, William T. Curry, Tracy T. Batchelor, Jörg Dietrich · 2012 · Nature Reviews Clinical Oncology
62. EGFR heterogeneity and implications for therapeutic intervention in glioblastoma
    Eskil Eskilsson, Gro Vatne Røsland, Gergely Morten Solecki, Qianghu Wang, Patrick N. Harter, Grazia Graziani, Roel G.W. Verhaak, Frank Winkler, Rolf Bjerkvig, Hrvoje Miletić · 2017 · Neuro-Oncology
63. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
    Farshad Nassiri, Vikas S. Patil, Leeor S. Yefet, Olivia Singh, Jeff Liu, Rachel M. A. Dang, Takafumi N. Yamaguchi, Mariza Daras, Timothy Francis Cloughesy, Howard Colman et al. · 2023 · Nature Medicine
64. Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
    Richard A. Morgan, Laura A. Johnson, Jeremy L. Davis, Zhili Zheng, Kevin Woolard, Elizabeth A. Reap, Steven A. Feldman, Nachimuthu Chinnasamy, Chien-Tsun Kuan, Hua Song et al. · 2012 · Human Gene Therapy
65. U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
    Michael James Clark, Nils Homer, Brian D. O’Connor, Zugen Chen, Ascia Eskin, Hane Lee, Barry Merriman, Stanley F. Nelson · 2010 · PLoS Genetics
66. Cancer stem cells: Radioresistance, prediction of radiotherapy outcome and specific targets for combined treatments
    Mechthild Krause, Anna Dubrovska, Annett Linge, Michael A. Baumann · 2016 · Advanced Drug Delivery Reviews
67. Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis
    Michael T. C. Poon, Cathie L. M. Sudlow, Jonine D. Figueroa, Paul Martin Brennan · 2020 · Scientific Reports
68. Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection
    Jing Zhang, Chen Chen, Anning Li, Weiqiang Jing, Peng Sun, Xueyang Huang, Yingchao Liu, Shengchang Zhang, Wei Du, Rui Zhang et al. · 2021 · Nature Nanotechnology
69. Mechanisms regulating glioma invasion
    Ivy Paw, Richard L. Carpenter, Kounosuke Watabe, Waldemar Debinski, Hui‐Wen Lo · 2015 · Cancer Letters
70. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
    Satya Siva Kishan Yalamarty, Nina Filipczak, Xiang Li, Md Abdus Subhan, Farzana Parveen, Janaína Artem Ataide, Bharat Ashok Rajmalani, Vladimir P. Torchilin · 2023 · Cancers
71. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
    FABIO MASSAITI IWAMOTO, Lauren E. Abrey, Kathryn P. Beal, Philip H. Gutin, Marc K. Rosenblum, Victor E. Reuter, Lisa Marie DeAngelis, Andrew B. Lassman · 2009 · Neurology
72. Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
    Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, Donatella De Feo, Nicolás Gonzalo Núñez, Cassandra Stowe, Ekaterina Friebel, Francesco Nannini, Lukas Rindlisbacher, Thomas A. Roberts et al. · 2021 · Nature Communications
73. Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics
    Camilla Krakstad, Martha Chekenya · 2010 · Molecular Cancer
74. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
    Chenfei Lu, Yutian Wei, Xiefeng Wang, Zhuoran Zhang, Jianxing Yin, Wentao Li, Lijiu Chen, Xiao Lyu, Zhumei Shi, Wei Yan et al. · 2020 · Molecular Cancer
75. Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
    Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer, Luis A Sanchez-Perez, Smita K. Nair, Robert J. Schmittling, Pam Norberg, Weihua Xie, James E. Herndon, Patrick N Healy et al. · 2017 · Clinical Cancer Research
76. Brain Tumors
    Jose Ricardo McFaline-Figueroa, Eudocia Q. Lee · 2018 · The American Journal of Medicine
77. Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies
    Ashkan Pouyan, Masoud Ghorbanlo, Masoud Eslami, Majid Jahanshahi, Ehsan Ziaei, Ali Salami, Khatere Mokhtari, Koorosh Shahpasand, Najma Farahani, Tohid Emami Meybodi et al. · 2025 · Molecular Cancer
78. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
    Jörg Felsberg, Niklas Thon, Sabina Eigenbrod, Bettina Hentschel, Michael Sabel, Manfred Westphal, Gabriele Schackert, Friedrich Wilhelm Kreth, Torsten Pietsch, Markus Löffler et al. · 2011 · International Journal of Cancer
79. CircNT5E Acts as a Sponge of miR-422a to Promote Glioblastoma Tumorigenesis
    Renjie Wang, Sai Zhang, Xuyi Chen, Nan Li, Jianwei Li, Ruichao Jia, Yuanqing Pan, Haiqian Liang · 2018 · Cancer Research
80. Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions
    Min Tang, Qi Xie, Ryan C. Gimple, Zheng Zhong, Trevor Tam, Jing Tian, Reilly L. Kidwell, Qiulian Wu, Briana C. Prager, Zhixin Qiu et al. · 2020 · Cell Research
81. A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy
    Jeffery J. Raizer, Lauren E. Abrey, Andrew B. Lassman, Susan Marina Chang, Kathleen R. Lamborn, John G. Kuhn, W.K. Alfred Yung, Mark R. Gilbert, K. Aldape, Patrick Yung Wen et al. · 2009 · Neuro-Oncology
82. Nonsurgical Treatment of Recurrent Glioblastoma
    Oscar S. Gallego · 2015 · Current Oncology
83. Intracavity generation of glioma stem cell–specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy
    Chen Chen, Weiqiang Jing, Yu Chen, Ganyu Wang, Mohnad Abdalla, Lin Gao, Maosen Han, Chongdeng Shi, Anning Li, Peng Sun et al. · 2022 · Science Translational Medicine
84. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain
    Sagar Agarwal, Ramola Sane, Rajneet K. Oberoi, John R. Ohlfest, William F. Elmquist · 2011 · Expert Reviews in Molecular Medicine
85. A review of glioblastoma immunotherapy
    Ravi Teja Medikonda, Gavin P. Dunn, Maryam Rahman, Peter Edward Fecci, Michael K. Lim · 2020 · Journal of Neuro-Oncology
86. Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy
    Jason V. Gregory, Padma Kadiyala, Robert Doherty, Melissa Cadena, Samer Habeel, Erkki Ruoslahti, Pedro Ricardo Lowenstein, Maria Graciela Castro, Joerg Lahann · 2020 · Nature Communications
87. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
    Matthew J. McGirt, Khoi D. Than, JON D. WEINGART, Kaisorn Lee Chaichana, Frank Joseph Attenello, Alessandro Olivi, John Laterra, Lawrence Richard Kleinberg, Stuart A. Grossman, Henry Brem et al. · 2008 · Journal of neurosurgery
88. Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)
    MOSS Raymond lloyd · 2013 · Applied Radiation and Isotopes
89. Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
    Émilie Allard-Vannier, Catherine Passirani, Jean‐Pierre Benoît · 2009 · Biomaterials
90. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
    Sameer Agnihotri, Gelareh Mohammed Zadeh · 2015 · Neuro-Oncology
91. Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
    Alan T. Yeo, Shruti Rawal, Bethany Delcuze, Anthos Christofides, Agata M. P. Atayde, Laura Strauss, Leonora Balaj, Vaughn A. Rogers, Erik J. Uhlmann, Hemant Varma et al. · 2022 · Nature Immunology
92. Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma
    Dagmar Beier, Stefanie Röhrl, Deepu R. Pillai, Stefanie Schwarz, Leoni A. Kunz‐Schughart, Petra Leukel, Martin Andreas Proescholdt, Alexander T. Brawanski, Ulrich Bogdahn, Ariane Trampe-Kieslich et al. · 2008 · Cancer Research
93. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence
    Brenda Auffinger, Drew A. Spencer, Peter Pytel, Atique U. Ahmed, Maciej S. Lesniak · 2015 · Expert Review of Neurotherapeutics
94. Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial
    Thomas Sandmann, Richard Bourgon, Josep Garcia, Congfen Li, Timothy Francis Cloughesy, Olivier Louis Chinot, Wolfgang Wick, Ryo Nishikawa, Warren P. Mason, Roger Henriksson et al. · 2015 · Journal of Clinical Oncology
95. Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
    Jean-michel Lemée M. D, Anne Clavreul, Philippe Meneï · 2015 · Neuro-Oncology
96. When Immune Cells Turn Bad—Tumor-Associated Microglia/Macrophages in Glioma
    Saskia Roesch, Carmen Rapp, Steffen Dettling, Christel C. Herold‐Mende · 2018 · International Journal of Molecular Sciences
97. 5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas
    Keon Mahmoudi, Katherine L. Garvey, Andrew Bouras, Gwendolyn M. Cramer, Herbert G. Stepp, Joe Gerald Jesu Raj, Dominique Bozec, Theresa M. Busch, Costas G. Hadjipanayis · 2019 · Journal of Neuro-Oncology
98. IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma
    Songtao Qi, Lei Yu, Si Gui, Ding YanQing, Han HuiXia, Zhang Xue-lin, Wu Lanxiao, Yao Fei · 2011 · Cancer Science
99. Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma
    Burt Nabors, Tom Mikkelsen, Steven S. Rosenfeld, Fred H. Hochberg, N. Shastry Akella, Joy D. Fisher, Gretchen A. Cloud, Yu Zhang, K. Carson, Sabine M. Wittemer et al. · 2007 · Journal of Clinical Oncology
100. Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy
     Tanner Michael Johanns, Christopher A. Miller, Ian G. Dorward, Christina I. Tsien, Edward F. Chang, Arie Perry, Ravindra Uppaluri, Cole Ferguson, Robert E. Schmidt, Sonika M Dahiya et al. · 2016 · Cancer Discovery